Long-term prognostic impact of hyperuricemia in community

References

• Wu AH, Gladden JD, Ahmed M, et al. Relation of serum uric acid to cardiovascular disease. Int J Cardiol. 2016;213:4–7.
   PubMed Web of Science ®Google Scholar
• Bombelli M, Ronchi I, Volpe M, et al. Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality. J Hypertens. 2014;32:1237–1244.
   PubMed Web of Science ®Google Scholar
• Strasak A, Ruttmann E, Brant L, et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem. 2008;54:273–284.
   PubMed Web of Science ®Google Scholar
• Ndrepepa G, Cassese S, Braun S, et al. A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease. Nutr Metab Cardiovasc Dis. 2013;23:1195–1201.
   PubMed Web of Science ®Google Scholar
• Storhaug HM, Norvik JV, Toft I, et al. Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study. BMC Cardiovasc Disord. 2011;13:115.
   Web of Science ®Google Scholar
• Fang J, Alderman MH. Serum Uric Acid and Cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey. JAMA. 2000;283:2404–2410.
   PubMed Web of Science ®Google Scholar
• Culleton BF, Larson MG, Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131:7–13.
   PubMed Web of Science ®Google Scholar
• Grayson PC, Young Kim S, Lavalley M, et al. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63:102–110.
   PubMed Web of Science ®Google Scholar
• Borghi C, Rosei EA, Bardin T, et al. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015;33:1729–1741.
   PubMed Web of Science ®Google Scholar
• Chugh SS, Reinier K, Teodorescu C, et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis. 2008;51:213–228.
   PubMed Web of Science ®Google Scholar
• Lewek J, Kaczmarek K, Cygankiewicz I, et al. Inflammation and arrhythmias: potential mechanisms and clinical implications. Expert Rev Cardiovasc Ther. 2014;12:1077–1085.
   PubMedGoogle Scholar
• Hussein AA, Gottdiener JS, Bartz TM, et al. Inflammation and sudden cardiac death in a community-based population of older adults: the cardiovascular health study. Heart Rhythm. 2013;10:1425–1432.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Kurl S, Zaccardi F, et al. Baseline and long-term fibrinogen levels and risk of sudden cardiac death: a new prospective study and meta-analysis. Atherosclerosis. 2016;245:171–180.
   PubMed Web of Science ®Google Scholar
• Reunanen A, Aromaa A, Pyorala K, et al. The social insurance institution’s coronary heart disease study. Baseline data and 5-year mortality experience. Acta Med Scand Suppl. 1983;673:1–120.
   PubMedGoogle Scholar
• Rose GA, Blackburn H. Cardiovascular survey methods. Monogr Ser World Health Organ. 1968;56:1–188.
   PubMedGoogle Scholar
• Levey AS, Stevens LA, Schmid CH, et al. Article annals of internal medicine a new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:204–212.
   Web of Science ®Google Scholar
• Heistaro S. editor. Methodology report: health 2000 survey. Helsinki, Finland: National Public Health Institute; 2008.
   Google Scholar
• Aromaa A, Reunanen A, Impivaara O, et al. The execution of the mini-Finland health survey. Helsinki and Turku, Finland: Social Insurance Institution; 1985.
   Google Scholar
• Greene HL, Richardson DW, Barker AH, et al. Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study). Am J Cardiol. 1989;63:1–6.
   PubMed Web of Science ®Google Scholar
• Tikkanen JT, Anttonen O, Junttila MJ, et al. Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med. 2009;361:2529–2537.
   PubMed Web of Science ®Google Scholar
• Rapola JM, Virtamo J, Korhonen P, et al. Validity of diagnoses of major coronary events in national registers of hospital diagnoses and deaths in Finland. Eur J Epidemiol. 1997;13:133–138.
   PubMed Web of Science ®Google Scholar
• Kellgren JH, Jeffery MR, Ball JF. The epidemiology of chronic rheumatism. Vol 1. Oxford: Blackwell Scientific; 1963.
   Google Scholar
• Winer BJ. Statistical principles in experimental design. 2nd ed. Tokyo: MCGraw-Hill and Kogakusha; 1971.
   Google Scholar
• SAS II. SAS/STAT 9.3 user’s guide. Cary (NC): SAS Institute Inc.; 2009.
   Google Scholar
• Meisinger C, Koenig W, Baumert J, et al. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population the MONICA ORA cohort study. Arterioscler Thromb Vasc Biol. 2008;28:1186–1192.
   PubMed Web of Science ®Google Scholar
• Stack AG, Hanley A, Casserly LF, et al. Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality. QJM. 2013;106:647–658.
   PubMed Web of Science ®Google Scholar
• Reunanen A, Takkunen H, Knekt P, et al. Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand. 2009;212:49–59.
   Google Scholar
• Anton FM, Garcia Puig J, Ramos T, et al. Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17 beta (E2) on the renal handling of urate. Metab Clin Exp. 1986;35:343–348.
   PubMed Web of Science ®Google Scholar
• Mikuls TR, Farrar JT, Bilker WB, et al. Gout epidemiology: results from the UK general practice research database, 1990–1999. Ann Rheum Dis. 2005;64:267–272.
   PubMed Web of Science ®Google Scholar
• Arromdee E, Michet CJ, Crowson CS, et al. Epidemiology of gout: is the incidence rising? J Rheumatol. 2002;29:2403–2406.
   PubMed Web of Science ®Google Scholar
• Goldstein RA, Becker KL, Moore CF. Serum urate in healthy men. Intermittent elevations and seasonal effect. N Engl J Med. 1972;287:649–650.
   PubMed Web of Science ®Google Scholar
• Kang DH. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16:3553–3562.
   PubMed Web of Science ®Google Scholar
• Ruggiero C, Cherubini A, Miller IIIE, et al. Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years. Am J Cardiol. 2007;100:115–121.
   PubMed Web of Science ®Google Scholar
• Yamada S, Suzuki H, Kamioka M, et al. Uric acid increases the incidence of ventricular arrhythmia in patients with left ventricular hypertrophy. Fukushima J Med Sci. 2012;58:101–106.
   PubMedGoogle Scholar
• Silbernagel G, Hoffmann MM, Grammer TB, et al. Uric acid is predictive of cardiovascular mortality and sudden cardiac death in subjects referred for coronary angiography. Nutr Metab Cardiovasc Dis. 2013;23:46–52.
   PubMed Web of Science ®Google Scholar